These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 19246100)

  • 1. Efficacy of oral ribavirin treatment in Crimean-Congo haemorrhagic fever: a quasi-experimental study from Turkey.
    Elaldi N; Bodur H; Ascioglu S; Celikbas A; Ozkurt Z; Vahaboglu H; Leblebicioglu H; Yilmaz N; Engin A; Sencan M; Aydin K; Dokmetas I; Cevik MA; Dokuzoguz B; Tasyaran MA; Ozturk R; Bakir M; Uzun R
    J Infect; 2009 Mar; 58(3):238-44. PubMed ID: 19246100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy of oral ribavirin in the treatment of crimean-congo hemorrhagic fever in Iran.
    Mardani M; Jahromi MK; Naieni KH; Zeinali M
    Clin Infect Dis; 2003 Jun; 36(12):1613-8. PubMed ID: 12802764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the efficacy of ribavirin therapy on survival of Crimean-Congo hemorrhagic fever patients: a case-control study.
    Izadi S; Salehi M
    Jpn J Infect Dis; 2009 Jan; 62(1):11-5. PubMed ID: 19168952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy of ribavirin in the treatment of Crimean-Congo hemorrhagic fever in Eastern Black Sea region in Turkey.
    Koksal I; Yilmaz G; Aksoy F; Aydin H; Yavuz I; Iskender S; Akcay K; Erensoy S; Caylan R; Aydin K
    J Clin Virol; 2010 Jan; 47(1):65-8. PubMed ID: 19962342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of Crimean-Congo haemorrhagic fever successfully treated with therapeutic plasma exchange and ribavirin.
    Kurnaz F; Metan G; Coskun R; Kaynar L; Eser B; Doganay M
    Trop Doct; 2011 Jul; 41(3):181-2. PubMed ID: 21565949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of oral ribavirin treatment on the viral load and disease progression in Crimean-Congo hemorrhagic fever.
    Bodur H; Erbay A; Akıncı E; Öngürü P; Bayazıt N; Eren SS; Kubar A
    Int J Infect Dis; 2011 Jan; 15(1):e44-7. PubMed ID: 21106428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of patients with Crimean-Congo hemorrhagic fever in a recent outbreak in Turkey and impact of oral ribavirin therapy.
    Ergönül O; Celikbaş A; Dokuzoguz B; Eren S; Baykam N; Esener H
    Clin Infect Dis; 2004 Jul; 39(2):284-7. PubMed ID: 15307042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of risk-factors among patients with Crimean-Congo haemorrhagic fever virus infection: severity criteria revisited.
    Ergonul O; Celikbas A; Baykam N; Eren S; Dokuzoguz B
    Clin Microbiol Infect; 2006 Jun; 12(6):551-4. PubMed ID: 16700704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A preliminary study to evaluate the effect of intravenous ribavirin treatment on survival rates in Crimean-Congo hemorrhagic fever.
    Cevik MA; Elaldi N; Akinci E; Ongürü P; Erbay A; Buzgan T; Uzun R; Kubar A; Bodur H
    J Infect; 2008 Oct; 57(4):350-1. PubMed ID: 18722669
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of Crimean-Congo hemorrhagic fever.
    Ergonul O
    Antiviral Res; 2008 Apr; 78(1):125-31. PubMed ID: 18096251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crimean-Congo hemorrhagic fever in Eastern Turkey: clinical features, risk factors and efficacy of ribavirin therapy.
    Ozkurt Z; Kiki I; Erol S; Erdem F; Yilmaz N; Parlak M; Gundogdu M; Tasyaran MA
    J Infect; 2006 Mar; 52(3):207-15. PubMed ID: 15953646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible horizontal transmission of crimean-congo hemorrhagic Fever virus from a mother to her child.
    Saijo M; Tang Q; Shimayi B; Han L; Zhang Y; Asiguma M; Tianshu D; Maeda A; Kurane I; Morikawa S
    Jpn J Infect Dis; 2004 Apr; 57(2):55-7. PubMed ID: 15118210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early use of ribavirin is beneficial in Crimean-Congo hemorrhagic fever.
    Ozbey SB; Kader Ç; Erbay A; Ergönül Ö
    Vector Borne Zoonotic Dis; 2014 Apr; 14(4):300-2. PubMed ID: 24689859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythema nodosum in the course of Crimean-Congo haemorrhagic fever.
    Bijani B; Mardani M; Toosi P
    Trop Doct; 2010 Apr; 40(2):123-4. PubMed ID: 20305115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical investigation of the transient evoked otoacoustic emission test in Crimean-Congo hemorrhagic fever.
    Engin A; Yildirim A; Kunt T; Bakir M; Dokmetas I; Ozdemir L
    Int J Infect Dis; 2008 Mar; 12(2):162-5. PubMed ID: 17714968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current treatment of Crimean-Congo hemorrhagic fever in children.
    Mardani M; Rahnavardi M; Sharifi-Mood B
    Expert Rev Anti Infect Ther; 2010 Aug; 8(8):911-8. PubMed ID: 20695747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of PCR and ELISA-IgM results in the laboratory diagnosis of Crimean-Congo haemorrhagic fever cases in 2008 in Turkey].
    Uyar Y; Carhan A; Albayrak N; Altaş AB
    Mikrobiyol Bul; 2010 Jan; 44(1):57-64. PubMed ID: 20455399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crimean Congo haemorrhagic fever, precautions and ribavirin prophylaxis: a case report.
    Tütüncü EE; Gurbuz Y; Ozturk B; Kuscu F; Sencan I
    Scand J Infect Dis; 2009; 41(5):378-80. PubMed ID: 19343611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crimean-Congo hemorrhagic fever in Turkey.
    Karti SS; Odabasi Z; Korten V; Yilmaz M; Sonmez M; Caylan R; Akdogan E; Eren N; Koksal I; Ovali E; Erickson BR; Vincent MJ; Nichol ST; Comer JA; Rollin PE; Ksiazek TG
    Emerg Infect Dis; 2004 Aug; 10(8):1379-84. PubMed ID: 15496237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and laboratory features of Crimean-Congo hemorrhagic fever: predictors of fatality.
    Cevik MA; Erbay A; Bodur H; Gülderen E; Baştuğ A; Kubar A; Akinci E
    Int J Infect Dis; 2008 Jul; 12(4):374-9. PubMed ID: 18063402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.